These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Evaluation of intraoperative intraperitoneal administration on anti-cancer drug for gastric cancer].
    Author: Kosaka T, Hirano K, Takegawa S, Kitabayashi K, Gotoda H, Akiyama T, Kiriyama M, Saito H, Tomita F, Kita I.
    Journal: Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1734-7. PubMed ID: 1530344.
    Abstract:
    This study was undertaken in order to evaluate the effect of intraoperative intraperitoneal (IP) administration of cisplatin (CDDP) and/or mitomycin C (MMC) on patients who underwent an operation for gastric cancer, compared with an untreated group. There were no differences between the effect of CDDP and that of MMC. No differences were found between the survival rate of IP and untreated group in no liver and no peritoneal metastasis cases, nor in non-resection cases. However, the median survival time was longer at 377 days in IP group than at 213 days in the untreated group (p less than 0.1). The free CDDP levels in the serum after 50 mg IP injection remained effective for 15-30 min. On the other hand, the MMC levels in the serum after 20 mg IP proved in effective.
    [Abstract] [Full Text] [Related] [New Search]